Women, Girls, and People with the Potential to Menstruate Summit
The foundation hosts an inaugural summit focused on supporting the female and female-identifying population in Atlanta.
The foundation hosts an inaugural summit focused on supporting the female and female-identifying population in Atlanta.
In 2017, the foundation introduced the Guías Culturales program. Guías culturales, or cultural guides, are volunteers within the community who speak Spanish and have navigated care for themselves or family members.
In partnership with Mt. Sinai hospital, the foundation publishes clinical findings on oral surgery and dental care in a manual series called Treatment on Hemophilia.
NHF’s Medical and Scientific Advisory Council (MASAC) issued a standards-of-care recommendation in 2008 to assist pharmacies providing clotting factor concentrates for home use to patients with bleeding disorders.
Dr. James F. Garrett, director of federal research into vocational rehabilitation at the U.S. Department of Health, Education and Welfare, receives NHF's first-ever Humanitarian Award.
A 1968 Miami newspaper denotes Timmy Strohbach as "the first poster boy" of NHF.
NHF partners with McMaster University to create guidelines for hemophilia management care models.
Physician-researchers conduct a survey on behalf of NHF's Medical and Scientific Advisory Council to gauge current practices regarding newborn intracranial hemorrhage and obstetrical care and mode of delivery of pregnant hemophilia carriers. The survey queried obstetricians, neonatologists, and hematologists in the United States.
Over the course of 18 months, NHF worked with chapters throughout the U.S. to learn more about the nature and needs of adolescents with hemophilia. Results were presented at the 1968 meeting of the World Federation of Hemophilia in Montreal, and were also published in the December 1969 of Vocational Guidance Quarterly.
At the 1965 meeting of the World Federation of Hemophilia in Paris, Dr. Martin Rosenthal, NHF's medical advisor, presents on the importance and responsibility of his role and that of the Medical Advisory Council of NHF.
On November 8, 2004, Ann-Marie Nazzaro, PhD and Lauren Daitch, MPH, presented novel VWD findings from an NHF and CDC designed study via Project Red Flag about women's knowledge of VWD. The presentation occurred at a meeting of the American Public Health Association.
NHF partners with the AIDS Memorial Grove and the Hemophilia Federation of America to open a Hemophilia Memorial Circle in Golden Gate Park.
Donald Goldman, Esq., an attorney, who was active in the National Hemophilia Foundation and its chapters for over 25 years joins the National Commission on AIDS among other advocates and medical experts. He coordinated the National Hemophilia Foundation's efforts to improve the safety of the nation's blood supply, began many of its efforts in HIV risk reduction, and introduced initiatives to improve delivery of hemophilia and HIV services to minorities.
On December 2, 1986, NHF executive director Alan Brownstein penned a letter to Surgeon General C. Everett Koop in response to the first Surgeon General's Report on AIDS. Brownstein noted that the report would help "dispel ignorance and prevent discrimination" while also educating and informing.
NHF hosts its 66th annual Bleeding Disorders Conference.
NHF hosts a Steps for Success event titled, "Hemophilia Pharmacy Management: Steps for Success With Managed Care and Specialty Pharmacy" that was designed to meet the educational needs of specialty pharmacists, home health pharmacists, health plan pharmacists, managed Medicaid pharmacists, medical directors, and other health care professionals with an interest in the management of patients with hemophilia.
On January 17, 1983, NHF issued a statement calling on manufacturers of blood products to refuse blood donations by Gay men.
A 10-year study on joint damage run by NHF medical trustee Henry H. Jordan concludes. A few years later, Henry would publish a monograph on his findings involving 56 hemophilia patients.
In 1946, Dr. Henry Jordan, a surgeon and medical trustee of NHF, began a program for the orthopedic treatment of hemophilia patients. The study was funded and conducted in cooperation with NHF, and was run out of Lenox Hill Hospital in New York City. The study included 110 patients and ran through 1956.
Dr. Henry Jordan, a trustee of the medical advisory council of the National Hemophilia Foundation, publishes a well-received book on treatments for hemophilic arthropathy (joint damage). The research cases featured in the book were funded by NHF.
Lee, the son of NHF's founders, was born in 1941* but was not diagnosed with hemophilia until he experienced an abdominal bleed 14 months later. *NOTE: Some public records indicate Lee's birth year as "about 1942" despite NHF's official record memos having his birth year listed as 1941.
Dr. Henry H. Jordan, an orthopedic surgeon who was a pioneer in the orthopedic treatment of hemophiliacs passed his way. Throughout his career, much of his work was funded by NHF.
NHF marks its 50th anniversary with a special issue of HemAware.
NHF launches a golf fundraising event.
NHF in collaboration with ASH, ISTH, and WFH, publishes guidelines on the diagnosis and management of von Willebrand disease.
NHF announces it will partner with ASH, ISTH, and WFH to create clinical practice guidelines for the diagnosis and management of von Willebrand Disease (VWD).
NHF launches Hemophilia Walk program, which becomes Unite for Bleeding Disorders. The first year featured walks in five different cities.
NHF establishes HANDI (Hemophilia and AIDS/HIV Network for the Dissemination of Information).
The NHI received the NHF's Research and Scientific Achievement Award for its "medical leadership ... tremendous stimulation and support of research activities directly related to the study and treatment of hemophilia."
On June 15, 1948, Robert Lee Henry files a Certificate of Incorporation with the State of New York Department of State for the Hemophilia Foundation.
The foundation announces a rebrand -- changing the organization name and look to "National Bleeding Disorders Foundation" -- that is more inclusive of all inheritable blood and bleeding disorders.
NHF launches the Dr. Marion Koerper Research Fund to support new research initiatives.
NHF hosts its first ever Health Equity Summit to start the conversation in ensuring equitable access and quality care for those with inheritable blood disorders.
Dr. Amy Dunn becomes the second female physician to chair MASAC.
The Judith Graham Pool Research Fellowship celebrates 50 years of progress, hope, and discovery.
NHF launches its first-ever "Start the Conversation" campaign to raise awareness throughout Bleeding Disorders Awareness Month.
Val Bias, NHF's longtime CEO, passes away on December 30, 2021.
The first-ever recipients of the Jeanne Marie Lusher Fellowship are announced.
NHF hosts virtual State of the Science Research Summit to help shape the National Research Blueprint
NHF launches Research Journal Club to bring researchers and community members together to discuss the latest science and innovative breakthroughs
NHF refocuses its mission statement to reflect a renewed emphasis on research and an expanded scope to include inheritable blood disorders.
NHF hosts a launch party for Super Seven, its new children’s book for kids with rare bleeding disorders.
NHF announces that its newest fellowship, named in honor of Jeanne Marie Lusher, will prioritize diverse researchers.
NHF enters another five-year cooperative agreement with the CDC to provide educational programming.
MyBDC -- NHF's patient dashboard -- rebrands to Community Voices in Research (CVR).
For the first time in BDC's history, the conference is announced as going virtual.
Dr. Leonard Valentino succeeds Val Bias as NHF CEO, becoming the first hematologist to assume this role.
Val Bias, NHF's CEO, retires after 11 years of service.
"MyBDC" -- NHF's patient dashboard -- launches.
NHF celebrates its 70th anniversary.
NHF launches the "Red Tie Campaign."
The NHF Annual Meeting rebrands to become the "Bleeding Disorders Conference" at the annual gathering in 2018.
NHF's signature fundraising event, the Spring Soiree, rebrands to become the Red Tie Soiree.
MASAC updates and approves camp standards.
NHF revises and republishes its popular publication "Playing it Safe."
NHF launches the Red Tie Challenge.
NHF launches Better You Know, an online risk assessment tool for people experiencing signs and symptoms of bleeding disorders.
HANDI library goes digital.
The National Hemophilia Foundation (NHF) conducted a summit meeting of stakeholders on von Willebrand disease (VWD) on November 21, 2014, in Washington, DC. The purpose of the summit was to discuss and develop a strategic approach for raising awareness of VWD and improving patient access to care in the evolving health care environment. The 38 summit participants included key figures in VWD research, care, and policy with representatives of such stakeholders as VWD patients and families, clinicians, payers, the pharmaceutical industry, and relevant federal agencies.
Following overviews of clinical and scientific aspects of VWD and patient perspectives and challenges, summit participants addressed four main issue areas: (1) recognizing and addressing stigma and marginalization, (2) clinical challenges, (3) hemophilia treatment center (HTC) and physician recognition and focus on VWD, and (4) organizational recognition and focus on VWD. For each issue area, the summit then moved to potential strategies and related next steps for NHF and VWD stakeholders to address the challenges and unmet needs.
NHF celebrates its 65th anniversary.
NHF launches "My Life, Our Future" genotyping program.
NHF hosts its first-ever Spring Soiree fundraising event.
Val Bias, a longtime community member and advocate, becomes NHF's CEO.
Between July 2008 and May 2009, CDC and NHF conducted a follow-up survey, the results of which were compared with data from the national baseline survey. The follow-up survey focused on many of the same areas as the baseline survey, including knowledge, attitudes, and behaviors associated with key prevention activities among youth and adults with hemophilia. In addition, the 2008–2009 follow-up survey collected information about the dissemination of the national “Do the 5!” prevention campaign messages and message recall of consumers. Both evaluations targeted adult men with hemophilia, parents of sons with hemophilia aged 9 years or younger, and youth aged 13–21 with hemophilia. Throughout this evaluation, findings showed the impact of the National Prevention program and the extent that target audience members are aware of, and able to recall, the prevention messages of the “Do the 5!” campaign.
NHF announces partnership with race car driver Marco Andretti.
NHF updates a popular 1996 publication about children safety during physical activities and retitles it "Playing it Safe."
The first-ever NHF Inhibitor Summit takes place in Philadelphia.
NHF provides support to Gulf area HTCs and families in the wake of Hurricane Katrina.
NHF launches its "Connections for Learning" travel grant programs to allow more families to attend the annual conference.
In 2003, NHF launched a Clinical Fellowships program that allows early career physicians to train with mentors at hemophilia treatment centers (HTCs) across the country.
NHF launches NYLI, the National Youth Leadership Institute, providing18- to 24-year-olds with a bleeding disorder, or those who have a sibling with one, leadership opportunities to “encourage personal growth, effect change and positively influence others.”
The NHF and CDC conducted a survey, completed in March 2000, aimed at ascertaining knowledge about, attitudes toward, and behaviors associated with key prevention activities among people with hemophilia.
In 2000, NHF launched Project Red Flag with program partners from the the Centers for Disease Control and Prevention. The national campaign had the aptly phrased tagline, “real talk about women’s bleeding disorders."
NHF launches a Career Development Award to support and fund researchers.
From September 1999 through February 2000, NHF and CDC conducted a national baseline telephone survey to assess prevention knowledge and health practices in the hemophilia community to inform development of an effective national prevention program. Survey results and knowledge in the field were used to identify priority messages for NHF’s National Prevention Program (NPP). The NPP is a public awareness campaign targeting people affected by bleeding disorders, their families, and health care providers. The NPP’s theme is “Do the 5!,” which includes the following five strategies for living a longer and healthier life:
Get an annual comprehensive checkup at a hemophilia treatment center.
Get vaccinated—hepatitis A and B are preventable.
Treat bleeds early and adequately.
Exercise and maintain a healthy weight to protect your joints.
Get tested regularly for bloodborne infections.
NHF elects its first female board president, Katherine Muir.
NHF launches the "It's Time for a Cure!" campaign.
NHF forms a "Women with Bleeding Disorders Task Force" for the first time.
NHF's magazine, HemAware, debuts its inaugural issue.
In 1996, the National Hemophilia Foundation initiated an annual Gene Therapy and Novel Technologies Workshop to bring together immunologists, clinicians, and researchers in gene therapy. Over two decades later, the Gene Therapy Workshop still continues today.
MASAC issues recommendations for prophylaxis treatment for individuals with r factor VIII or r factor IX.
Dr. Jeanne Lusher becomes the first female chair of MASAC.
The camp subcommittee of NHF's Nursing Executive Committee develops the first Hemophilia Camp Program Standards.
NHF enters a co-op agreement with the CDC to provide education, resources, and programming.
Dr. Glenn Pierce, a physician with hemophilia, runs for NHF president on a platform of reforming the organization to meet the community’s demands. Pierce appointed Val Bias, a MANN leader, as chairman of the board once elected.
NHF launches the Women’s Outreach Network of NHF (WONN) and the Men’s Advocacy Network of NHF (MANN).
Robert Lee Henry, NHF's founder, passes away.
NHF is accredited by the Combined Federal Campaign.
George King was elected president of NHF.
NHF launches the Judith Graham Pool Research Fellowship.
NHF launches the Lee Henry Ferguson Scholarship, a financial aid award for students, which goes on until 1982.
Hemophilia of Michigan opens Camp Bold Eagle, the first summer camp to serve the bleeding disorders community in the U.S.
NHF's first medical director, Dr. Martin Rosenthal, passes away suddenly from a heart attack.
First NHF Award of Excellence is given.
John Walsh replaces Coring Jr. as the NHF executive director.
NHF hosts another symposium; MASAC again presents its findings and publishes a paper.
Lee Henry Ferguson passes away due to complications from hemophilia.
NHF hosts another symposium; MASAC presents its findings and publishes a paper.
Howard Coring Jr. is hired as the first official executive director of NHF.
Dr. Martin Rosenthal is named NHF's first medical director.
NHF hosts its first symposium where MASAC presents its findings.
At a board meeting in Chicago, NHF hands over business functions from volunteers to official staff, an effort lead by board secretary Margaret Hexter, who lived in Illinois and had a son with hemophilia.
On February 21, 1956, a "Certificate of Change of Name of The Hemophilia Foundation, Inc., to "The National Hemophilia Foundation" is filed in the New York Department of State.
Dr. Kenneth Brinkhous is named as the first president of MASAC.
The first meeting of NHF's Medical and Scientific Advisory Committee (MASAC) is held.
NHF is deemed a charitable organization by the U.S. Internal Revenue Service.
While on a subway train in NYC, Robert Lee Henry reads an article that inspires him to form NHF.